BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 2427475)

  • 1. Early pregnancy screening for neural tube defects in Israel.
    Legum C; Shomrat R; Yedwab G; Jaffa AJ; Rudick A
    Isr J Med Sci; 1986; 22(3-4):210-4. PubMed ID: 2427475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Routine assessment of amniotic fluid alpha-Fetoprotein in early second-trimester amniocentesis is no longer justified.
    Widlund KF; Gottvall T
    Acta Obstet Gynecol Scand; 2007; 86(2):167-71. PubMed ID: 17364279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periodic health examination, 1994 update: 3. Primary and secondary prevention of neural tube defects. Canadian Task Force on the Periodic Health Examination.
    CMAJ; 1994 Jul; 151(2):159-66. PubMed ID: 7518734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prenatal detection of open neural tube defects in a mass screening program by determination of alpha-fetoprotein concentration in maternal serum].
    Zwahr C; Körner H; Tinschert S; Horn A; Schulze M; Voigt M
    Zentralbl Gynakol; 1988; 110(3):158-67. PubMed ID: 2452529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated maternal serum alpha-fetoprotein values. How low is high?
    Lenke RR; Guerrieri J; Nemes JM; Kurczynski TW; French B; Gray M; Schut H; Ashwood ER
    J Reprod Med; 1989 Aug; 34(8):511-6. PubMed ID: 2478705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on key techniques and intervention in reducing birth defects].
    Zhu BS; Su J; Lu XH; He J; Zhu S; Jiao CX; Zhang JM; Tang XH; Tao Y; Lin KP; Chen H; Li SY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):658-63. PubMed ID: 22176989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routine ultrasonography compared with maternal serum alpha-fetoprotein for neural tube defect screening.
    Norem CT; Schoen EJ; Walton DL; Krieger RC; O'Keefe J; To TT; Ray GT
    Obstet Gynecol; 2005 Oct; 106(4):747-52. PubMed ID: 16199631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal oculocerebrorenal syndrome of Lowe associated with elevated maternal serum and amniotic fluid alpha-fetoprotein levels.
    Miller RC; Wolf EJ; Gould M; Macri CJ; Charnas LR
    Obstet Gynecol; 1994 Jul; 84(1):77-80. PubMed ID: 7516514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal diagnosis policy without routine amniocentesis in pregnancies with a positive family history for neural tube defects.
    Papp Z; Tóth Z; Török O; Szabó M
    Am J Med Genet; 1987 Jan; 26(1):103-10. PubMed ID: 2433941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated maternal serum alpha-fetoprotein with normal ultrasound: is amniocentesis always appropriate? A review of 26,069 screened patients.
    Richards DS; Seeds JW; Katz VL; Lingley LH; Albright SG; Cefalo RC
    Obstet Gynecol; 1988 Feb; 71(2):203-7. PubMed ID: 2447540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal serum alpha-fetoprotein screening: promise not yet fulfilled.
    Nadler HL; Simpson JL
    Am J Obstet Gynecol; 1979 Sep; 135(1):1-2. PubMed ID: 89812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Increased AFP in maternal serum as an indication for invasive diagnosis].
    Gremm B; Sohn C; Beldermann F; Bastert G
    Zentralbl Gynakol; 1997; 119(11):560-6. PubMed ID: 9480612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal serum alpha-fetoprotein screening: report of a Canadian pilot project.
    Doran TA; Valentine GH; Wong PY; Wielgosz G; Benzie RJ; Soltan HC; Jenner MR; Morland PA; Montgomery RJ; Allen LC
    CMAJ; 1987 Aug; 137(4):285-93. PubMed ID: 2440547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved reliability of a serum alpha-fetoprotein enzyme immunoassay compared with a radioimmunoassay.
    Peleg L; Slor H; Cordova T; Ayalon D; Legum C; Rudick A
    Isr J Med Sci; 1986; 22(3-4):215-9. PubMed ID: 2427476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results and benefits of a maternal serum alpha-fetoprotein screening program.
    Milunsky A; Alpert E
    JAMA; 1984 Sep; 252(11):1438-42. PubMed ID: 6206249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated maternal serum alpha-fetoprotein and amniotic fluid alpha-fetoprotein after multifetal pregnancy reduction.
    Grau P; Robinson L; Tabsh K; Crandall BF
    Obstet Gynecol; 1990 Dec; 76(6):1042-5. PubMed ID: 1700349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-year results of routine alpha-fetoprotein testing on prenatal patients in a family practice.
    Weiss BD
    J Fam Pract; 1988 Mar; 26(3):273-80. PubMed ID: 2450166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal testing for maternal serum alpha-fetoprotein.
    Schwager EJ; Weiss BD
    Am Fam Physician; 1987 Apr; 35(4):169-74. PubMed ID: 2436465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT
    CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha-Fetoprotein screening.
    Burton BK
    Adv Pediatr; 1986; 33():181-96. PubMed ID: 2432763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.